This video features a discussion between Jay Taylor and Chen Lin about investment strategies and market outlooks, particularly focusing on precious metals like silver and gold, as well as junior mining companies. They also touch upon broader economic and political factors influencing these markets, including potential policy changes and geopolitical events.
NerveGen Pharma is a biotech company that has listed on NASDAQ under the symbol N. Since Chen Lin last discussed it, the stock has more than doubled. The company has been featured on Fox News and ABC News, with its stock performance improving significantly after people saw videos demonstrating its potential to help individuals with spinal cord injuries walk again.
Currently listed on NASDAQ, NerveGen Pharma's future performance is dependent on its progress with the FDA. Chen Lin expects the company to conduct a significant funding round this year, which would fully finance its operations for an extended period. He has taken some profits but believes the stock has strong future potential, especially after the expected funding round, as it aims to help people with spinal cord injuries regain mobility and potentially has other neurological applications.
Chen Lin highlights several junior mining companies as promising investments: